logo

For the Inventor, By the Inventor

Irving, TX, United States of America

Caris Science, Inc.


USPTO Granted Patents = 14



Trademarks = 12

Forward Citations = 11

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal David Spetzler (10 out of 21 patents)

silverMedal Mark Miglarese (9 out of 9 patents)

bronzeMedal Heather O'Neill (7 out of 7 patents)

4.  Tassilo Hornung (5 out of 7 patents)

5.  Valeriy Domenyuk (5 out of 10 patents)

6.  Clive Gavin Brown (4 out of 55 patents)

7.  Koen Kas (4 out of 14 patents)

8.  Sven Agnes Jan Eyckerman (4 out of 5 patents)

9.  Günter Mayer (3 out of 9 patents)

10.  David D Halbert (1 out of 3 patents)

11.  Frank Schafer (1 out of 2 patents)

12.  Nianqing Xiao (1 out of 2 patents)

13.  Adam Stark (1 patent)

14.  Zhenyu Zhong (0 patent)

15.  Michael Famulok (0 patent)


14 patents:

1. 12606814 - Oligonucleotide probes and uses thereof (2026-04-21),
2. 12398172 - Therapeutic oligonucleotides (2025-08-26),
3. 12116618 - Use of aptamers in proteomics (2024-10-15),
4. 11725023 - Therapeutic oligonucleotides (2023-08-15),
5. 11624083 - Use of aptamers in proteomics (2023-04-11),
6. 11332748 - Oligonucleotide probes and uses thereof (2022-05-17),
7. 11293017 - Oligonucleotide probes and uses thereof (2022-04-05),
8. 11091765 - Therapeutic oligonucleotides (2021-08-17),
9. 10995360 - Use of aptamers in proteomics (2021-05-04),
10. 10942184 - Aptamers and uses thereof (2021-03-09),
11. 10941176 - Therapeutic oligonucleotides (2021-03-09),
12. 10731166 - Oligonucleotide probes and uses thereof (2020-08-04),
13. 10590425 - Therapeutic oligonucleotides (2020-03-17),
14. 10316349 - Use of aptamers in proteomics (2019-06-11),
Company Overview
Caris Science, Inc. is a biotechnology company based in Irving, Texas, specializing in precision medicine and advanced genomic profiling. The organization focuses on developing innovative diagnostic solutions that enhance patient care by providing insights into the molecular characteristics of diseases, particularly cancer. Through its cutting-edge technologies, Caris aims to facilitate personalized treatment strategies, thereby improving clinical outcomes and advancing the field of oncology. The company is committed to transforming healthcare through data-driven approaches and comprehensive biomarker analysis.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#27 in Irving, TX

#1,378 in Texas

#22,333 in US

#42,290 in the World

Irving, TX (US)
Irving, TX, United States of America

Caris Science, Inc.

Forward Citations = 11

13 inventors:

goldMedal David Spetzler (10 out of 21 patents)

silverMedal Mark Miglarese (9 out of 9 patents)

bronzeMedal Heather O'Neill (7 out of 7 patents)

4.  Tassilo Hornung (5 out of 7 patents)

5.  Valeriy Domenyuk (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Caris Science, Inc.. Retrieved from https://idiyas.com/company/caris-science

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…